All In Biotech

Drug Trial Radar · NCT04770753

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Mitapivat in Subjects With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (ENERGIZE)

Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 194 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

194

Actual

Start

Dec 20, 2021

Primary completion

Nov 13, 2023

Study completion Dec 2028

Sponsor

Lead sponsor
Agios Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Feb 25, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study was to compare the effect of mitapivat versus placebo on hemolytic anemia in participants with alpha- or beta-non-transfusion dependent thalassemia (NTDT).

Conditions

  • Non-Transfusion-dependent Alpha-Thalassemia
  • Non-Transfusion-dependent Beta-Thalassemia

Interventions

  • Placebo Matching MitapivatDrug

    Tablets

  • MitapivatDrug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Double-Blind Period: Percentage of Participants Who Achieved Hemoglobin (Hb) Response From Week 12 Through Week 24 Compared With BaselineTime frame: Double-Blind Period: Baseline up to Week 12 through Week 24

Locations

68 sites in 18 countries. Site status is shown where the registry gives one.

  • San Diego Hospital, UC San Diego Health

    La Jolla, California

  • Stanford Medicine

    Palo Alto, California

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Weill Cornell Medical Center

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Penn Medicine - University of Pennsylvania Health System

    Philadelphia, Pennsylvania

  • Universidade de Caxias do Sul

    Caxias do Sul, Brazil

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

    Ribeirão Preto, Brazil

  • HEMORIO Instituto Nacional de Hematologia

    Rio de Janeiro, Brazil

  • Praxis Pesquisa Medica

    Santo André, Brazil

  • GSH Banco de Sangue de São Paulo

    São Paulo, Brazil

  • Instituto do Cancer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidad de São Paulo

    São Paulo, Brazil

  • MHAT "Dr. Nikola Vasiliev" AD

    Kyustendil, Bulgaria

  • SHATHD Sofia

    Sofia, Bulgaria

  • Toronto General Hospital, University Health Network

    Toronto, Canada

  • Rigshospitalet

    Copenhagen, Denmark

  • CHU Hôpital Henri Mondor

    Créteil, France

  • Hopital Edouard Herriot, CHU de Lyon

    Lyon, France

  • Laiko General Hospital

    Athens, Greece

  • Children's Hospital Agia Sophia, National and Kapodistrian University of Athens Medical School

    Athens, Greece

  • University General Hospital of Patras

    Rio, Greece

  • Ippokrateio General Hospital

    Thessaloniki, Greece

  • Ospedale "A. Perrino" - Brindisi

    Brindisi, Italy

  • Ospedale Pediatrico Microcitemico

    Cagliari, Italy

  • Ospedale Sant'Anna

    Ferrara, Italy

  • Ente Ospedaliero Ospedali Galliera

    Genova, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • A.O.U Di Modena

    Modena, Italy

  • A.O.R.N. "A. Cardarelli"

    Naples, Italy

  • AOU L. Vanvitelli Universita degli Studi della Campania Luigi Vanvitelli

    Naples, Italy

  • A.O.U. San Luigi Gonzaga

    Orbassano, Italy

  • Chronic Care Center

    Beirut, Lebanon

  • Hospital Sultanah Bahiyah

    Alor Star, Malaysia

  • Hospital Ampang

    Ampang, Malaysia

  • Hospital Sultanah Aminah Johor Bahru

    Johor Bahru, Malaysia

  • Hospital Queen Elizabeth, Kota Kinabalu

    Kota Kinabalu, Malaysia

  • Hospital Tunku Azizah

    Kuala Lumpur, Malaysia

  • Hospital Tengku Ampuan Afzan

    Kuantan, Malaysia

  • Hospital Umum Sarawak

    Kuching, Malaysia

  • Hospital Pulau Pinang

    Pulau Pinang, Malaysia

Showing 40 of 68 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.